<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33525344</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>28</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Glial Cell Dysfunction in <i>C9orf72</i>-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">249</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells10020249</ELocationID><Abstract><AbstractText>Since the discovery of the chromosome 9 open reading frame 72 (<i>C9orf72</i>) repeat expansion mutation in 2011 as the most common genetic abnormality in amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease) and frontotemporal dementia (FTD), progress in understanding the signaling pathways related to this mutation can only be described as intriguing. Two major theories have been suggested-(i) loss of function or haploinsufficiency and (ii) toxic gain of function from either <i>C9orf72</i> repeat RNA or dipeptide repeat proteins (DPRs) generated from repeat-associated non-ATG (RAN) translation. Each theory has provided various signaling pathways that potentially participate in the disease progression. Dysregulation of the immune system, particularly glial cell dysfunction (mainly microglia and astrocytes), is demonstrated to play a pivotal role in both loss and gain of function theories of <i>C9orf72</i> pathogenesis. In this review, we discuss the pathogenic roles of glial cells in <i>C9orf72</i> ALS/FTD as evidenced by pre-clinical and clinical studies showing the presence of gliosis in <i>C9orf72</i> ALS/FTD, pathologic hallmarks in glial cells, including TAR DNA-binding protein 43 (TDP-43) and p62 aggregates, and toxicity of <i>C9orf72</i> glial cells. A better understanding of these pathways can provide new insights into the development of therapies targeting glial cell abnormalities in <i>C9orf72</i> ALS/FTD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ghasemi</LastName><ForeName>Mehdi</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1384-9826</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01655, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keyhanian</LastName><ForeName>Kiandokht</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01655, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Douthwright</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01655, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C9orf72 gene</Keyword><Keyword MajorTopicYN="N">C9orf72 repeat expansion mutation</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">astrocytes</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia (FTD)</Keyword><Keyword MajorTopicYN="N">glial cells</Keyword><Keyword MajorTopicYN="N">microglia</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>2</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33525344</ArticleId><ArticleId IdType="pmc">PMC7912327</ArticleId><ArticleId IdType="doi">10.3390/cells10020249</ArticleId><ArticleId IdType="pii">cells10020249</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zucchi E., Ticozzi N., Mandrioli J. Psychiatric Symptoms in Amyotrophic Lateral Sclerosis: Beyond a Motor Neuron Disorder. Front. Neurosci. 2019;13:175. doi: 10.3389/fnins.2019.00175.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00175</ArticleId><ArticleId IdType="pmc">PMC6421303</ArticleId><ArticleId IdType="pubmed">30914912</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M., Brown R.H., Jr. Genetics of Amyotrophic Lateral Sclerosis. Cold Spring Harb. Perspect. Med. 2018;8:a024125. doi: 10.1101/cshperspect.a024125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024125</ArticleId><ArticleId IdType="pmc">PMC5932579</ArticleId><ArticleId IdType="pubmed">28270533</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sarraj S., King A., Troakes C., Smith B., Maekawa S., Bodi I., Rogelj B., Al-Chalabi A., Hortob&#xe1;gyi T., Shaw C.E. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol. 2011;122:691&#x2013;702. doi: 10.1007/s00401-011-0911-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0911-2</ArticleId><ArticleId IdType="pubmed">22101323</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Hewitt C., Highley J.R., Brockington A., Milano A., Man S., Martindale J., Hartley J., Walsh T., Gelsthorpe C., et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain. 2012;135:751&#x2013;764. doi: 10.1093/brain/awr365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr365</ArticleId><ArticleId IdType="pmc">PMC3286332</ArticleId><ArticleId IdType="pubmed">22366792</ArticleId></ArticleIdList></Reference><Reference><Citation>Schipper L.J., Raaphorst J., Aronica E., Baas F., De Haan R.J., De Visser M., Troost D. Prevalence of brain and spinal cord inclusions, including dipeptide repeat proteins, in patients with the C9ORF72 hexanucleotide repeat expansion: A systematic neuropathological review. Neuropathol. Appl. Neurobiol. 2016;42:547&#x2013;560. doi: 10.1111/nan.12284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12284</ArticleId><ArticleId IdType="pubmed">26373655</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim&#xf3;n-S&#xe1;nchez J., Dopper E.G.P., Cohn-Hokke P.E., Hukema R.K., Nicolaou N., Seelaar H., De Graaf J.R.A., De Koning I., Van Schoor N.M., Deeg D.J.H., et al. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain. 2012;135:723&#x2013;735. doi: 10.1093/brain/awr353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr353</ArticleId><ArticleId IdType="pubmed">22300876</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J., Ravits J.M. Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia. Neurotherapeutics. 2019;16:1115&#x2013;1132. doi: 10.1007/s13311-019-00797-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-019-00797-2</ArticleId><ArticleId IdType="pmc">PMC6985338</ArticleId><ArticleId IdType="pubmed">31667754</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., MacKenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., Van Swieten J.C., Myllykangas L., et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I., Van Langenhove T., Van Der Zee J., Sleegers K., Philtjens S., Kleinberger G., Janssens J., Bettens K., Van Cauwenberghe C., Pereson S., et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: A gene identification study. Lancet Neurol. 2012;11:54&#x2013;65. doi: 10.1016/S1474-4422(11)70261-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70261-7</ArticleId><ArticleId IdType="pubmed">22154785</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H.P., Van Broeckhoven C., Van Der Zee J. ALS Genes in the Genomic Era and their Implications for FTD. Trends Genet. 2018;34:404&#x2013;423. doi: 10.1016/j.tig.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler A.R., Donnelly C.J., Rothstein J.D. The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease. Nat. Rev. Neurosci. 2016;17:383&#x2013;395. doi: 10.1038/nrn.2016.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2016.38</ArticleId><ArticleId IdType="pmc">PMC7376590</ArticleId><ArticleId IdType="pubmed">27150398</ArticleId></ArticleIdList></Reference><Reference><Citation>Cammack A.J., Atassi N., Hyman T., Van Den Berg L.H., Harms M., Baloh R.H., Brown R.H., Van Es M.A., Veldink J.H., De Vries B.S., et al. Prospective natural history study of C9orf72 ALS clinical characteristics and biomarkers. Neurology. 2019;93:e1605&#x2013;e1617. doi: 10.1212/WNL.0000000000008359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008359</ArticleId><ArticleId IdType="pmc">PMC6946465</ArticleId><ArticleId IdType="pubmed">31578300</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S.C., Elamin M., Bede P., Shatunov A., Walsh C., Corr B., Heverin M., Jordan N., Kenna K., Lynch C., et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: A population-based cohort study. Lancet Neurol. 2012;11:232&#x2013;240. doi: 10.1016/S1474-4422(12)70014-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70014-5</ArticleId><ArticleId IdType="pmc">PMC3315021</ArticleId><ArticleId IdType="pubmed">22305801</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S., Boill&#xe9;e S., Le Ber I., Seilhean D., Teyssou E., Giraudeau M., Moigneu C., Vandenberghe N., Danel-Brunaud V., Corcia P., et al. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. J. Med. Genet. 2012;49:258&#x2013;263. doi: 10.1136/jmedgenet-2011-100699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2011-100699</ArticleId><ArticleId IdType="pubmed">22499346</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Borghero G., Restagno G., Mora G., Drepper C., Traynor B.J., Sendtner M., Brunetti M., Ossola I., Calvo A., et al. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain. 2012;135:784&#x2013;793. doi: 10.1093/brain/awr366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr366</ArticleId><ArticleId IdType="pmc">PMC3286333</ArticleId><ArticleId IdType="pubmed">22366794</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin D.J., McMillan C.T., Brettschneider J., Libon D.J., Powers J., Rascovsky K., Toledo J.B., Boller A., Bekisz J., Chandrasekaran K., et al. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2013;84:163&#x2013;169. doi: 10.1136/jnnp-2012-303507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-303507</ArticleId><ArticleId IdType="pmc">PMC3543474</ArticleId><ArticleId IdType="pubmed">23117491</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden J.S., Adams J., Harris J., Thompson J.C., Rollinson S., Richardson A., Jones M.J., Neary D., Mann D.M., Pickering-Brown S. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations. Amyotroph. Lateral Scler. Front. Degener. 2015;16:497&#x2013;505. doi: 10.3109/21678421.2015.1074700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1074700</ArticleId><ArticleId IdType="pubmed">26473392</ArticleId></ArticleIdList></Reference><Reference><Citation>Picher-Martel V., Valdmanis P.N., Gould P.V., Julien J.-P., Dupre N. From animal models to human disease: A genetic approach for personalized medicine in ALS. Acta Neuropathol. Commun. 2016;4:1&#x2013;29. doi: 10.1186/s40478-016-0340-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0340-5</ArticleId><ArticleId IdType="pmc">PMC4940869</ArticleId><ArticleId IdType="pubmed">27400686</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciura S., Lattante S., Le Ber I., Latouche M., Tostivint H., Brice A., Kabashi E. Loss of function of C9orf72 causes motor deficits in a zebrafish model of Amyotrophic Lateral Sclerosis. Ann. Neurol. 2013;74:180&#x2013;187. doi: 10.1002/ana.23946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23946</ArticleId><ArticleId IdType="pubmed">23720273</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P., Poulter M., Lashley T., Rohrer J.D., Polke J.M., Beck J., Ryan N., Hensman D., Mizielinska S., Waite A.J., et al. Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia. Acta Neuropathol. 2013;126:401&#x2013;409. doi: 10.1007/s00401-013-1147-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1147-0</ArticleId><ArticleId IdType="pmc">PMC3753468</ArticleId><ArticleId IdType="pubmed">23818065</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil V.V., Bauer P.O., Prudencio M., Gendron T.F., Stetler C.T., Yan I.K., Pregent L., Daughrity L., Baker M.C., Rademakers R., et al. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol. 2013;126:895&#x2013;905. doi: 10.1007/s00401-013-1199-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1199-1</ArticleId><ArticleId IdType="pmc">PMC3830740</ArticleId><ArticleId IdType="pubmed">24166615</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite A.J., B&#xe4;umer D., East S., Neal J., Morris H.R., Ansorge O., Blake D.J. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol. Aging. 2014;35:1779.e5&#x2013;1779.e13. doi: 10.1016/j.neurobiolaging.2014.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.01.016</ArticleId><ArticleId IdType="pmc">PMC3988882</ArticleId><ArticleId IdType="pubmed">24559645</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Blitterswijk M., Gendron T.F., Baker M.C., DeJesus-Hernandez M., Finch N.A., Brown P.H., Daughrity L.M., Murray M.E., Heckman M.G., Jiang J., et al. Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72. Acta Neuropathol. 2015;130:863&#x2013;876. doi: 10.1007/s00401-015-1480-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1480-6</ArticleId><ArticleId IdType="pmc">PMC4655160</ArticleId><ArticleId IdType="pubmed">26437865</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly C.J., Zhang P.-W., Pham J.T., Haeusler A.R., Mistry N.A., Vidensky S., Daley E.L., Poth E.M., Hoover B., Fines D.M., et al. RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention. Neuron. 2013;80:415&#x2013;428. doi: 10.1016/j.neuron.2013.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.10.015</ArticleId><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters O.M., Ghasemi M., Brown R.H., Jr. Emerging mechanisms of molecular pathology in ALS. J. Clin. Investig. 2015;125:1767&#x2013;1779. doi: 10.1172/JCI71601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI71601</ArticleId><ArticleId IdType="pmc">PMC4463186</ArticleId><ArticleId IdType="pubmed">25932674</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran H., Almeida S., Moore J.M., Gendron T.F., Chalasani U., Lu Y., Du X., Nickerson J.A., Petrucelli L., Weng Z., et al. Differential Toxicity of Nuclear RNA Foci versus Dipeptide Repeat Proteins in a Drosophila Model of C9ORF72 FTD/ALS. Neuron. 2015;87:1207&#x2013;1214. doi: 10.1016/j.neuron.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC4589299</ArticleId><ArticleId IdType="pubmed">26402604</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzu P., Blauwendraat C., Heetveld S., Lynes E.M., Castillo-Lizardo M., Dhingra A., Pyz E., Hobert M., Synofzik M., Sim&#xf3;n-S&#xe1;nchez J., et al. C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers. Acta Neuropathol. Commun. 2016;4:37. doi: 10.1186/s40478-016-0306-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0306-7</ArticleId><ArticleId IdType="pmc">PMC4832459</ArticleId><ArticleId IdType="pubmed">27079381</ArticleId></ArticleIdList></Reference><Reference><Citation>Frick P., Sellier C., MacKenzie I.R.A., Cheng C.-Y., Tahraoui-Bories J., Martinat C., Pasterkamp R.J., Prudlo J., Edbauer D., Oulad-Abdelghani M., et al. Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers. Acta Neuropathol. Commun. 2018;6:72. doi: 10.1186/s40478-018-0579-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0579-0</ArticleId><ArticleId IdType="pmc">PMC6091050</ArticleId><ArticleId IdType="pubmed">30075745</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S., Macnair L., McGoldrick P., McKeever P.M., McLean J.R., Zhang M., Keith J., Zinman L., Rogaeva E., Robertson J. Isoform-specific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral sclerosis. Ann. Neurol. 2015;78:568&#x2013;583. doi: 10.1002/ana.24469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24469</ArticleId><ArticleId IdType="pubmed">26174152</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkinson R., Fernandez-Martos C.M., Atkin J.D., Vickers J.C., King A.E. C9ORF72 expression and cellular localization over mouse development. Acta Neuropathol. Commun. 2015;3:59. doi: 10.1186/s40478-015-0238-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0238-7</ArticleId><ArticleId IdType="pmc">PMC4582620</ArticleId><ArticleId IdType="pubmed">26408000</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K., Weng S.-M., Arzberger T., May S., Rentzsch K., Kremmer E., Schmid B., Kretzschmar H.A., Cruts M., Van Broeckhoven C., et al. The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS. Science. 2013;339:1335&#x2013;1338. doi: 10.1126/science.1232927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida S., Gascon E., Tran H., Chou H.J., Gendron T.F., DeGroot S., Tapper A.R., Sellier C., Charlet-Berguerand N., Karydas A., et al. Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol. 2013;126:385&#x2013;399. doi: 10.1007/s00401-013-1149-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1149-y</ArticleId><ArticleId IdType="pmc">PMC3753484</ArticleId><ArticleId IdType="pubmed">23836290</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Lin S., Staats K.A., Li Y., Chang W.-H., Hung S.-T., Hendricks E., Linares G.R., Wang Y., Son E.Y., et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat. Med. 2018;24:313&#x2013;325. doi: 10.1038/nm.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Z., Zinman L., Moreno D., Schymick J., Liang Y., Sato C., Zheng Y., Ghani M., Dib S., Keith J., et al. Hypermethylation of the CpG Island Near the G4C2 Repeat in ALS with a C9orf72 Expansion. Am. J. Hum. Genet. 2013;92:981&#x2013;989. doi: 10.1016/j.ajhg.2013.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2013.04.017</ArticleId><ArticleId IdType="pmc">PMC3675239</ArticleId><ArticleId IdType="pubmed">23731538</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Iyer L.M., He F., Aravind L. Discovery of Novel DENN Proteins: Implications for the Evolution of Eukaryotic Intracellular Membrane Structures and Human Disease. Front. Genet. 2012;3:283. doi: 10.3389/fgene.2012.00283.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2012.00283</ArticleId><ArticleId IdType="pmc">PMC3521125</ArticleId><ArticleId IdType="pubmed">23248642</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster C.P., Smith E.F., Bauer C.S., Moller A., Hautbergue G.M., Ferraiuolo L., Myszczynska M.A., Higginbottom A., Walsh M.J., Whitworth A.J., et al. The C9orf72 protein interacts with Rab1a and the ULK 1 complex to regulate initiation of autophagy. EMBO J. 2016;35:1656&#x2013;1676. doi: 10.15252/embj.201694401.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201694401</ArticleId><ArticleId IdType="pmc">PMC4969571</ArticleId><ArticleId IdType="pubmed">27334615</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster C.P., Smith E.F., Grierson A.J., De Vos K.J. C9orf72 plays a central role in Rab GTPase-dependent regulation of autophagy. Small GTPases. 2018;9:399&#x2013;408. doi: 10.1080/21541248.2016.1240495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21541248.2016.1240495</ArticleId><ArticleId IdType="pmc">PMC5997165</ArticleId><ArticleId IdType="pubmed">27768524</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer S., Subramanian V., Acharya K.R. C9orf72, a protein associated with amyotrophic lateral sclerosis (ALS) is a guanine nucleotide exchange factor. PeerJ. 2018;6:e5815. doi: 10.7717/peerj.5815.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.5815</ArticleId><ArticleId IdType="pmc">PMC6195791</ArticleId><ArticleId IdType="pubmed">30356970</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg M.A., Sundaramoorthy V., Sultana J.M., Yang S., Atkinson R.A., Levina V., Halloran M.A., Gleeson P.A., Blair I.P., Soo K.Y., et al. C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum. Mol. Genet. 2014;23:3579&#x2013;3595. doi: 10.1093/hmg/ddu068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu068</ArticleId><ArticleId IdType="pmc">PMC4049310</ArticleId><ArticleId IdType="pubmed">24549040</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden A.C., Kim H.-J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X., Armakola M., Geser F., Greene R., Lu M.M., et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069&#x2013;1075. doi: 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Daoud H., Belzil V., Martins S., Sabbagh M., Provencher P., Lacomblez L., Meininger V., Camu W., Dupr&#xe9; N., Dion P.A., et al. Association of Long ATXN2 CAG Repeat Sizes with Increased Risk of Amyotrophic Lateral Sclerosis. Arch. Neurol. 2011;68:739&#x2013;742. doi: 10.1001/archneurol.2011.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.111</ArticleId><ArticleId IdType="pubmed">21670397</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross O.A., Rutherford N.J., Baker M., Soto-Ortolaza A.I., Carrasquillo M.M., DeJesus-Hernandez M., Adamson J., Li M., Volkening K., Finger E., et al. Ataxin-2 repeat-length variation and neurodegeneration. Hum. Mol. Genet. 2011;20:3207&#x2013;3212. doi: 10.1093/hmg/ddr227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr227</ArticleId><ArticleId IdType="pmc">PMC3140823</ArticleId><ArticleId IdType="pubmed">21610160</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S., Millecamps S., Stevanin G., Rivaud-P&#xe9;choux S., Moigneu C., Camuzat A., Da Barroca S., Mundwiller E., Couarch P., Salachas F., et al. Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders. Neurology. 2014;83:990&#x2013;995. doi: 10.1212/WNL.0000000000000778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000778</ArticleId><ArticleId IdType="pmc">PMC4162303</ArticleId><ArticleId IdType="pubmed">25098532</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C., Campanari M.-L., Corbier C.J., Gaucherot A., Kolb-Cheynel I., Oulad-Abdelghani M., Ruffenach F., Page A., Ciura S., Kabashi E., et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J. 2016;35:1276&#x2013;1297. doi: 10.15252/embj.201593350.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593350</ArticleId><ArticleId IdType="pmc">PMC4910533</ArticleId><ArticleId IdType="pubmed">27103069</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudria-Lopez E., Koppers M., De Wit M., Van Der Meer C., Westeneng H.-J., Zundel C.A.C., Youssef S.A., Harkema L., De Bruin A., Veldink J.H., et al. Full ablation of C9orf72 in mice causes immune system-related pathology and neoplastic events but no motor neuron defects. Acta Neuropathol. 2016;132:145&#x2013;147. doi: 10.1007/s00401-016-1581-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1581-x</ArticleId><ArticleId IdType="pmc">PMC4911370</ArticleId><ArticleId IdType="pubmed">27206760</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki Y., Manzano R., Lee Y., Dafinca R., Aoki M., Douglas A.G.L., Varela M.A., Sathyaprakash C., Scaber J., Barbagallo P., et al. C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia. Brain. 2017;140:887&#x2013;897. doi: 10.1093/brain/awx024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx024</ArticleId><ArticleId IdType="pubmed">28334866</ArticleId></ArticleIdList></Reference><Reference><Citation>Amick J., Roczniak-Ferguson A., Ferguson S.M. C9orf72 binds SMCR8, localizes to lysosomes, and regulates mTORC1 signaling. Mol. Biol. Cell. 2016;27:3040&#x2013;3051. doi: 10.1091/mbc.e16-01-0003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e16-01-0003</ArticleId><ArticleId IdType="pmc">PMC5063613</ArticleId><ArticleId IdType="pubmed">27559131</ArticleId></ArticleIdList></Reference><Reference><Citation>Burk K., Pasterkamp R.J. Disrupted neuronal trafficking in amyotrophic lateral sclerosis. Acta Neuropathol. 2019;137:859&#x2013;877. doi: 10.1007/s00401-019-01964-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01964-7</ArticleId><ArticleId IdType="pmc">PMC6531423</ArticleId><ArticleId IdType="pubmed">30721407</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber L.A., Pimplikar S., Parton R.G., Virta H., Zerial M., Simons K. Rab8, a small GTPase involved in vesicular traffic between the TGN and the basolateral plasma membrane. J. Cell Biol. 1993;123:35&#x2013;45. doi: 10.1083/jcb.123.1.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.123.1.35</ArticleId><ArticleId IdType="pmc">PMC2119815</ArticleId><ArticleId IdType="pubmed">8408203</ArticleId></ArticleIdList></Reference><Reference><Citation>King A.E., Woodhouse A., Kirkcaldie M.T., Vickers J.C. Excitotoxicity in ALS: Overstimulation, or overreaction? Pt 1Exp. Neurol. 2016;275:162&#x2013;171. doi: 10.1016/j.expneurol.2015.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.09.019</ArticleId><ArticleId IdType="pubmed">26584004</ArticleId></ArticleIdList></Reference><Reference><Citation>Bursch F., Kalmbach N., Naujock M., Staege S., Eggenschwiler R., Abo-Rady M., Japtok J., Guo W., Hensel N., Reinhardt P., et al. Altered calcium dynamics and glutamate receptor properties in iPSC derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations. Hum. Mol. Genet. 2019;28:2835&#x2013;2850. doi: 10.1093/hmg/ddz107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz107</ArticleId><ArticleId IdType="pubmed">31108504</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaraj B.T., Livesey M.R., Zhao C., Gregory J.M., James O.T., Cleary E.M., Chouhan A.K., Gane A.B., Perkins E.M., Dando O., et al. C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca2+-permeable AMPA receptor-mediated excitotoxicity. Nat. Commun. 2018;9:347. doi: 10.1038/s41467-017-02729-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02729-0</ArticleId><ArticleId IdType="pmc">PMC5783946</ArticleId><ArticleId IdType="pubmed">29367641</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore S., Alsop E., Lorenzini I., Starr A., Rabichow B.E., Mendez E., Levy J.L., Burciu C., Reiman R., Chew J., et al. ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD. Acta Neuropathol. 2019;138:49&#x2013;65. doi: 10.1007/s00401-019-01999-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01999-w</ArticleId><ArticleId IdType="pmc">PMC6750285</ArticleId><ArticleId IdType="pubmed">30945056</ArticleId></ArticleIdList></Reference><Reference><Citation>Hideyama T., Yamashita T., Suzuki T., Tsuji S., Higuchi M., Seeburg P.H., Takahashi R., Misawa H., Kwak S. Induced Loss of ADAR2 Engenders Slow Death of Motor Neurons from Q/R Site-Unedited GluR2. J. Neurosci. 2010;30:11917&#x2013;11925. doi: 10.1523/JNEUROSCI.2021-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2021-10.2010</ArticleId><ArticleId IdType="pmc">PMC6633551</ArticleId><ArticleId IdType="pubmed">20826656</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Hung S.-T., Rocha G., Lin S., Linares G.R., Staats K.A., Seah C., Wang Y., Chickering M., Lai J., et al. Identification and therapeutic rescue of autophagosome and glutamate receptor defects in C9ORF72 and sporadic ALS neurons. JCI Insight. 2019;4 doi: 10.1172/jci.insight.127736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.127736</ArticleId><ArticleId IdType="pmc">PMC6693831</ArticleId><ArticleId IdType="pubmed">31310593</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers M., Blokhuis A.M., Westeneng H., Terpstra M.L., Zundel C.A.C., De S&#xe1; R.V., Schellevis R.D., Waite A.J., Blake D.J., Veldink J.H., et al. C 9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Ann. Neurol. 2015;78:426&#x2013;438. doi: 10.1002/ana.24453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24453</ArticleId><ArticleId IdType="pmc">PMC4744979</ArticleId><ArticleId IdType="pubmed">26044557</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J., Zhu Q., Gendron T.F., Saberi S., McAlonis-Downes M., Seelman A., Stauffer J.E., Jafar-Nejad P., Drenner K., Schulte D., et al. Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs. Neuron. 2016;90:535&#x2013;550. doi: 10.1016/j.neuron.2016.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.006</ArticleId><ArticleId IdType="pmc">PMC4860075</ArticleId><ArticleId IdType="pubmed">27112497</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasio A., Decman V., White D., Ramos M., Ikiz B., Lee H.-C., Siao C.-J., Brydges S., LaRosa E., Bai Y., et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production and glomerulonephropathy in mice. Sci. Rep. 2016;6:23204. doi: 10.1038/srep23204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23204</ArticleId><ArticleId IdType="pmc">PMC4793236</ArticleId><ArticleId IdType="pubmed">26979938</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke J.G., Bogdanik L., Y&#xe1;&#xf1;ez A., Lall D., Wolf A.J., Muhammad A.K.M.G., Ho R., Carmona S., Vit J.P., Zarrow J., et al. C9orf72 is required for proper macrophage and microglial function in mice. Science. 2016;351:1324&#x2013;1329. doi: 10.1126/science.aaf1064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A., Suzuki N., Wang J.-Y., Moccia R., Mordes D.A., Stewart M.H., Suzuki-Uematsu S., Ghosh S., Singh A., Merkle F.T., et al. Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci. Transl. Med. 2016;8:347ra93. doi: 10.1126/scitranslmed.aaf6038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf6038</ArticleId><ArticleId IdType="pmc">PMC5024536</ArticleId><ArticleId IdType="pubmed">27412785</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugolino J., Ji Y.J., Conchina K., Chu J., Nirujogi R.S., Pandey A., Brady N.R., Hamacher-Brady A., Wang J. Loss of C9orf72 Enhances Autophagic Activity via Deregulated mTOR and TFEB Signaling. PLoS Genet. 2016;12:e1006443. doi: 10.1371/journal.pgen.1006443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1006443</ArticleId><ArticleId IdType="pmc">PMC5119725</ArticleId><ArticleId IdType="pubmed">27875531</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan P.M., Zhou X., Robins A.M., Paushter D.H., Kim D., Smolka M.B., Hu F. The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. Acta Neuropathol. Commun. 2016;4:51. doi: 10.1186/s40478-016-0324-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0324-5</ArticleId><ArticleId IdType="pmc">PMC4870812</ArticleId><ArticleId IdType="pubmed">27193190</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R., Isaacs A.M. C9orf72-mediated ALS and FTD: Multiple pathways to disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W., Philips T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2013;14:248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J., Gendron T.F., Prudencio M., Sasaguri H., Zhang Y.-J., Castanedes-Casey M., Lee C.W., Jansen-West K., Kurti A., Murray M.E., et al. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science. 2015;348:1151&#x2013;1154. doi: 10.1126/science.aaa9344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa9344</ArticleId><ArticleId IdType="pmc">PMC4692360</ArticleId><ArticleId IdType="pubmed">25977373</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron T.F., Bieniek K.F., Zhang Y.-J., Jansen-West K., Ash P.E.A., Caulfield T., Daughrity L., Dunmore J.H., Castanedes-Casey M., Chew J., et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 2013;126:829&#x2013;844. doi: 10.1007/s00401-013-1192-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1192-8</ArticleId><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K., Arzberger T., Gr&#xe4;sser F.A., Gijselinck I., May S., Rentzsch K., Weng S.-M., Schludi M.H., Van Der Zee J., Cruts M., et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 2013;126:881&#x2013;893. doi: 10.1007/s00401-013-1189-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1189-3</ArticleId><ArticleId IdType="pubmed">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T., Liu Y., Ba&#xf1;ez-Coronel M., Reid T., Pletnikova O., Lewis J., Miller T.M., Harms M.B., Falchook A.E., Subramony S.H., et al. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl. Acad. Sci. USA. 2013;110:E4968&#x2013;E4977. doi: 10.1073/pnas.1315438110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1315438110</ArticleId><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Baughn M., Rigo F., Sun S., Liu P., Li H.-R., Jiang J., Watt A.T., Chun S., Katz M., et al. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc. Natl. Acad. Sci. USA. 2013;110:E4530&#x2013;E4539. doi: 10.1073/pnas.1318835110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1318835110</ArticleId><ArticleId IdType="pmc">PMC3839752</ArticleId><ArticleId IdType="pubmed">24170860</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D., O&#x2019;Rourke J.G., Meera P., Muhammad A.K.M.G., Grant S., Simpkinson M., Bell S., Carmona S., Ornelas L., Sahabian A., et al. Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion. Sci. Transl. Med. 2013;5:208ra149. doi: 10.1126/scitranslmed.3007529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3007529</ArticleId><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada A.R., Taylor J.P. Repeat expansion disease: Progress and puzzles in disease pathogenesis. Nat. Rev. Genet. 2010;11:247&#x2013;258. doi: 10.1038/nrg2748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2748</ArticleId><ArticleId IdType="pmc">PMC4704680</ArticleId><ArticleId IdType="pubmed">20177426</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P., Mizielinska S., Nicoll A.J., Zloh M., Fisher E.M.C., Parkinson G.N., Isaacs A.M. C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes. Sci. Rep. 2012;2:srep01016. doi: 10.1038/srep01016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep01016</ArticleId><ArticleId IdType="pmc">PMC3527825</ArticleId><ArticleId IdType="pubmed">23264878</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Goodrich K.J., Conlon E.G., Gao J., Erbse A.H., Manley J.L., Cech T.R. C9orf72 and triplet repeat disorder RNAs: G-quadruplex formation, binding to PRC2 and implications for disease mechanisms. RNA. 2019;25:935&#x2013;947. doi: 10.1261/rna.071191.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.071191.119</ArticleId><ArticleId IdType="pmc">PMC6633194</ArticleId><ArticleId IdType="pubmed">31048495</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P. Neurodegenerative diseases: G-quadruplex poses quadruple threat. Nature. 2014;507:175&#x2013;177. doi: 10.1038/nature13067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13067</ArticleId><ArticleId IdType="pubmed">24598546</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Z., Zhang Y., Gendron T.F., Bauer P.O., Chew J., Yang W.-Y., Fostvedt E., Jansen-West K., Belzil V.V., Desaro P., et al. Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS. Neuron. 2014;83:1043&#x2013;1050. doi: 10.1016/j.neuron.2014.07.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.07.041</ArticleId><ArticleId IdType="pmc">PMC4232217</ArticleId><ArticleId IdType="pubmed">25132468</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler A.R., Donnelly C.J., Periz G., Simko E.A.J., Shaw P.G., Kim M.-S., Maragakis N.J., Troncoso J.C., Pandey A., Sattler R., et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature. 2014;507:195&#x2013;200. doi: 10.1038/nature13124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13124</ArticleId><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy K., Zamiri B., Stanley S.Y.R., MacGregor R.B., Pearson C.E. The Disease-associated r(GGGGCC) Repeat from the C9orf72 Gene Forms Tract Length-dependent Uni- and Multimolecular RNA G-quadruplex Structures. J. Biol. Chem. 2013;288:9860&#x2013;9866. doi: 10.1074/jbc.C113.452532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C113.452532</ArticleId><ArticleId IdType="pmc">PMC3617286</ArticleId><ArticleId IdType="pubmed">23423380</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Geng Y., Liu C., Miao H., Ren Y., Xu N., Shi X., You Y., Lee T., Zhu G. Characterizations of distinct parallel and antiparallel G-quadruplexes formed by two-repeat ALS and FTD related GGGGCC sequence. Sci. Rep. 2018;8:2366. doi: 10.1038/s41598-018-20852-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20852-w</ArticleId><ArticleId IdType="pmc">PMC5799222</ArticleId><ArticleId IdType="pubmed">29402965</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#x10d;i&#x107; J., Plavec J. NMR structure of a G-quadruplex formed by four d(G4C2) repeats: Insights into structural polymorphism. Nucleic Acids Res. 2018;46:11605&#x2013;11617. doi: 10.1093/nar/gky886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky886</ArticleId><ArticleId IdType="pmc">PMC6265483</ArticleId><ArticleId IdType="pubmed">30277522</ArticleId></ArticleIdList></Reference><Reference><Citation>Skourti-Stathaki K., Proudfoot N.J., Gromak N. Human Senataxin Resolves RNA/DNA Hybrids Formed at Transcriptional Pause Sites to Promote Xrn2-Dependent Termination. Mol. Cell. 2011;42:794&#x2013;805. doi: 10.1016/j.molcel.2011.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.04.026</ArticleId><ArticleId IdType="pmc">PMC3145960</ArticleId><ArticleId IdType="pubmed">21700224</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#xfc;ce &#xd6;., West S.C. Senataxin, Defective in the Neurodegenerative Disorder Ataxia with Oculomotor Apraxia 2, Lies at the Interface of Transcription and the DNA Damage Response. Mol. Cell. Biol. 2012;33:406&#x2013;417. doi: 10.1128/MCB.01195-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01195-12</ArticleId><ArticleId IdType="pmc">PMC3554130</ArticleId><ArticleId IdType="pubmed">23149945</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatovec S., Kovanda A., Rogelj B. Unconventional features of C9ORF72 expanded repeat in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Neurobiol. Aging. 2014;35:2421.e1&#x2013;2421.e12. doi: 10.1016/j.neurobiolaging.2014.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.04.015</ArticleId><ArticleId IdType="pubmed">24836899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovanda A., Zalar M., &#x160;ket P., Plavec J., Rogelj B. Anti-sense DNA d(GGCCCC)n expansions in C9ORF72 form i-motifs and protonated hairpins. Sci. Rep. 2015;5:17944. doi: 10.1038/srep17944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep17944</ArticleId><ArticleId IdType="pmc">PMC4668579</ArticleId><ArticleId IdType="pubmed">26632347</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Roland C., Sagui C. Structure and Dynamics of DNA and RNA Double Helices Obtained from the GGGGCC and CCCCGG Hexanucleotide Repeats That Are the Hallmark of C9FTD/ALS Diseases. ACS Chem. Neurosci. 2017;8:578&#x2013;591. doi: 10.1021/acschemneuro.6b00348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.6b00348</ArticleId><ArticleId IdType="pmc">PMC5423440</ArticleId><ArticleId IdType="pubmed">27933757</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash P.E., Bieniek K.F., Gendron T.F., Caulfield T., Lin W.-L., DeJesus-Hernandez M., Van Blitterswijk M.M., Jansen-West K., Paul J.W., III, Rademakers R., et al. Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS. Neuron. 2013;77:639&#x2013;646. doi: 10.1016/j.neuron.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X., Tan W., Westergard T., Krishnamurthy K., Markandaiah S.S., Shi Y., Lin S., Shneider N.A., Monaghan J., Pandey U.B., et al. Antisense Proline-Arginine RAN Dipeptides Linked to C9ORF72-ALS/FTD Form Toxic Nuclear Aggregates that Initiate In Vitro and In Vivo Neuronal Death. Neuron. 2014;84:1213&#x2013;1225. doi: 10.1016/j.neuron.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.010</ArticleId><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Z., Wang H., Xia Q., Li K., Li K., Jiang X., Xu G., Wang G., Ying Z. Nucleolar stress and impaired stress granule formation contribute to C9orf72 RAN translation-induced cytotoxicity. Hum. Mol. Genet. 2015;24:2426&#x2013;2441. doi: 10.1093/hmg/ddv005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv005</ArticleId><ArticleId IdType="pubmed">25575510</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K., Yagi T., Cammack A.J., Mahadevan J., Kuroda M., Harms M.B., Miller T.M., Urano F. Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation. Hum. Mol. Genet. 2016;25:1803&#x2013;1813. doi: 10.1093/hmg/ddw052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw052</ArticleId><ArticleId IdType="pmc">PMC4986334</ArticleId><ArticleId IdType="pubmed">26931465</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.-J., Jansen-West K., Xu Y.-F., Gendron T.F., Bieniek K.F., Lin W.-L., Sasaguri H., Caulfield T., Hubbard J., Daughrity L., et al. Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress. Acta Neuropathol. 2014;128:505&#x2013;524. doi: 10.1007/s00401-014-1336-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1336-5</ArticleId><ArticleId IdType="pmc">PMC4159567</ArticleId><ArticleId IdType="pubmed">25173361</ArticleId></ArticleIdList></Reference><Reference><Citation>May S., Hornburg D., Schludi M.H., Arzberger T., Rentzsch K., Schwenk B.M., Gr&#xe4;sser F.A., Mori K., Kremmer E., Banzhaf-Strathmann J., et al. C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration. Acta Neuropathol. 2014;128:485&#x2013;503. doi: 10.1007/s00401-014-1329-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1329-4</ArticleId><ArticleId IdType="pmc">PMC4159571</ArticleId><ArticleId IdType="pubmed">25120191</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamakawa M., Ito D., Honda T., Kubo K.-I., Noda M., Nakajima K., Suzuki N. Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS. Hum. Mol. Genet. 2015;24:1630&#x2013;1645. doi: 10.1093/hmg/ddu576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu576</ArticleId><ArticleId IdType="pubmed">25398948</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y.-J., Jeng U.-S., Chiang Y.-L., Hwang I.-S., Chen Y.-R. The Glycine-Alanine Dipeptide Repeat from C9orf72 Hexanucleotide Expansions Forms Toxic Amyloids Possessing Cell-to-Cell Transmission Properties. J. Biol. Chem. 2016;291:4903&#x2013;4911. doi: 10.1074/jbc.M115.694273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.694273</ArticleId><ArticleId IdType="pmc">PMC4777828</ArticleId><ArticleId IdType="pubmed">26769963</ArticleId></ArticleIdList></Reference><Reference><Citation>Swaminathan A., Bouffard M., Liao M., Ryan S., Callister J.B., Pickering-Brown S.M., Armstrong G.A.B., Drapeau P. Expression of C9orf72-related dipeptides impairs motor function in a vertebrate model. Hum. Mol. Genet. 2018;27:1754&#x2013;1762. doi: 10.1093/hmg/ddy083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy083</ArticleId><ArticleId IdType="pmc">PMC5932562</ArticleId><ArticleId IdType="pubmed">29528390</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Bento-Abreu A., Gendron T.F., Boeynaems S., Bogaert E., Nuyts R., Timmers M., Scheveneels W., Hersmus N., Wang J., et al. A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism. Acta Neuropathol. 2018;135:427&#x2013;443. doi: 10.1007/s00401-017-1796-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1796-5</ArticleId><ArticleId IdType="pubmed">29302778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohki Y., Wenninger-Weinzierl A., Hruscha A., Asakawa K., Kawakami K., Haass C., Edbauer D., Schmid B. Glycine-alanine dipeptide repeat protein contributes to toxicity in a zebrafish model of C9orf72 associated neurodegeneration. Mol. Neurodegener. 2017;12:6. doi: 10.1186/s13024-016-0146-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0146-8</ArticleId><ArticleId IdType="pmc">PMC5237533</ArticleId><ArticleId IdType="pubmed">28088213</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.-H., Zhang P., Kim H.J., Mitrea D.M., Sarkar M., Freibaum B.D., Cika J., Coughlin M., Messing J., Molliex A., et al. C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles. Cell. 2016;167:774&#x2013;788.e17. doi: 10.1016/j.cell.2016.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Lu Y., Lopez-Gonzalez R., Kim N.C., Almeida S., Lee K.-H., Badders N., Valentine M., Miller B.L., Wong P.C., et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.-J., Gendron T.F., Grima J.C., Sasaguri H., Jansen-West K., Xu Y.-F., Katzman R.B., Gass J., Murray M.E., Shinohara M., et al. C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nat. Neurosci. 2016;19:668&#x2013;677. doi: 10.1038/nn.4272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4272</ArticleId><ArticleId IdType="pmc">PMC5138863</ArticleId><ArticleId IdType="pubmed">26998601</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi M.H., Becker L., Garrett L., Gendron T.F., Zhou Q., Schreiber F., Popper B., Dimou L., Strom T.M., Winkelmann J., et al. Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss. Acta Neuropathol. 2017;134:241&#x2013;254. doi: 10.1007/s00401-017-1711-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1711-0</ArticleId><ArticleId IdType="pmc">PMC5508040</ArticleId><ArticleId IdType="pubmed">28409281</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D., Abdallah A., Li Z., Lu Y., Almeida S., Gao F.-B. FTD/ALS-associated poly(GR) protein impairs the Notch pathway and is recruited by poly(GA) into cytoplasmic inclusions. Acta Neuropathol. 2015;130:525&#x2013;535. doi: 10.1007/s00401-015-1448-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1448-6</ArticleId><ArticleId IdType="pmc">PMC4575383</ArticleId><ArticleId IdType="pubmed">26031661</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S., Gr&#xf6;nke S., Niccoli T., Ridler C.E., Clayton E.L., Devoy A., Moens T., Norona F.E., Woollacott I.O.C., Pietrzyk J., et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science. 2014;345:1192&#x2013;1194. doi: 10.1126/science.1256800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakae N., Bieniek K.F., Zhang Y.-J., Ross K., Gendron T.F., Murray M.E., Rademakers R., Petrucelli L., Dickson D. Poly-GR dipeptide repeat polymers correlate with neurodegeneration and Clinicopathological subtypes in C9ORF72-related brain disease. Acta Neuropathol. Commun. 2018;6:63. doi: 10.1186/s40478-018-0564-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0564-7</ArticleId><ArticleId IdType="pmc">PMC6054740</ArticleId><ArticleId IdType="pubmed">30029693</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon I., Xiang S., Kato M., Wu L., Theodoropoulos P., Wang T., Kim J., Yun J., Xie Y., McKnight S.L. Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science. 2014;345:1139&#x2013;1145. doi: 10.1126/science.1254917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1254917</ArticleId><ArticleId IdType="pmc">PMC4459787</ArticleId><ArticleId IdType="pubmed">25081482</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores B.N., Dulchavsky M., Krans A., Sawaya M.R., Paulson H.L., Todd P.K., Barmada S.J., Ivanova M.I. Distinct C9orf72-Associated Dipeptide Repeat Structures Correlate with Neuronal Toxicity. PLoS ONE. 2016;11:e0165084. doi: 10.1371/journal.pone.0165084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0165084</ArticleId><ArticleId IdType="pmc">PMC5077081</ArticleId><ArticleId IdType="pubmed">27776165</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Bogaert E., Kovacs D., Konijnenberg A., Timmerman E., Volkov A., Guharoy M., De Decker M., Jaspers T., Ryan V.H., et al. Phase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule Dynamics. Mol. Cell. 2017;65:1044&#x2013;1055.e5. doi: 10.1016/j.molcel.2017.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.02.013</ArticleId><ArticleId IdType="pmc">PMC5364369</ArticleId><ArticleId IdType="pubmed">28306503</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Daigle J.G., Cunningham K.M., Coyne A.N., Ruan K., Grima J.C., Bowen K.E., Wadhwa H., Yang P., Rigo F., et al. Stress Granule Assembly Disrupts Nucleocytoplasmic Transport. Cell. 2018;173:958&#x2013;971.e17. doi: 10.1016/j.cell.2018.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.025</ArticleId><ArticleId IdType="pmc">PMC6083872</ArticleId><ArticleId IdType="pubmed">29628143</ArticleId></ArticleIdList></Reference><Reference><Citation>White M.R., Mitrea D.M., Zhang P., Stanley C.B., Cassidy D.E., Nourse A., Phillips A.H., Tolbert M., Taylor J.P., Kriwacki R.W. C9orf72 Poly(PR) Dipeptide Repeats Disturb Biomolecular Phase Separation and Disrupt Nucleolar Function. Mol. Cell. 2019;74:713&#x2013;728.e6. doi: 10.1016/j.molcel.2019.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.03.019</ArticleId><ArticleId IdType="pmc">PMC6525025</ArticleId><ArticleId IdType="pubmed">30981631</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorter J. Phase separation of RNA-binding proteins in physiology and disease: An introduction to the JBC Reviews thematic series. J. Biol. Chem. 2019;294:7113&#x2013;7114. doi: 10.1074/jbc.REV119.007944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.REV119.007944</ArticleId><ArticleId IdType="pmc">PMC6509514</ArticleId><ArticleId IdType="pubmed">30948513</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi S., Serrano A., Gerbino V., Giorgi A., Di Francesco L., Nencini M., Bozzo F., Schinin&#xe0; M.E., Bagni C., Cestra G., et al. Nuclear accumulation of mRNAs underlies G4C2-repeat-induced translational repression in a cellular model of C9orf72 ALS. J. Cell Sci. 2015;128:1787&#x2013;1799. doi: 10.1242/jcs.165332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.165332</ArticleId><ArticleId IdType="pubmed">25788698</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens T.G., Niccoli T., Wilson K.M., Atilano M.L., Birsa N., Gittings L.M., Holbling B.V., Dyson M.C., Thoeng A., Neeves J., et al. C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A. Acta Neuropathol. 2019;137:487&#x2013;500. doi: 10.1007/s00401-018-1946-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1946-4</ArticleId><ArticleId IdType="pmc">PMC6514073</ArticleId><ArticleId IdType="pubmed">30604225</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W., Wang S., Mestre A.A., Fu C., Makarem A., Xian F., Hayes L.R., Lopez-Gonzalez R., Drenner K., Jiang J., et al. C9ORF72 GGGGCC repeat-associated non-AUG translation is upregulated by stress through eIF2&#x3b1; phosphorylation. Nat. Commun. 2018;9:51. doi: 10.1038/s41467-017-02495-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02495-z</ArticleId><ArticleId IdType="pmc">PMC5754368</ArticleId><ArticleId IdType="pubmed">29302060</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann H., Hornburg D., Czuppa M., Bader J.M., Michaelsen M., Farny D., Arzberger T., Mann M., Meissner F., Edbauer D. Proteomics and C9orf72 neuropathology identify ribosomes as poly-GR/PR interactors driving toxicity. Life Sci. Alliance. 2018;1:e201800070. doi: 10.26508/lsa.201800070.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.201800070</ArticleId><ArticleId IdType="pmc">PMC6238541</ArticleId><ArticleId IdType="pubmed">30456350</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.-J., Gendron T.F., Ebbert M.T.W., O&#x2019;Raw A.D., Yue M., Jansen-West K., Zhang X., Prudencio M., Chew J., Cook C.N., et al. Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis. Nat. Med. 2018;24:1136&#x2013;1142. doi: 10.1038/s41591-018-0071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0071-1</ArticleId><ArticleId IdType="pmc">PMC6520050</ArticleId><ArticleId IdType="pubmed">29942091</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R., Lu Y., Gendron T.F., Karydas A., Tran H., Yang D., Petrucelli L., Miller B.L., Almeida S., Gao F.-B. Poly(GR) in C9ORF72-Related ALS/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor Neurons. Neuron. 2016;92:383&#x2013;391. doi: 10.1016/j.neuron.2016.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S.Y., Lopez-Gonzalez R., Krishnan G., Phillips H.L., Li A.N., Seeley W.W., Yao W.-D., Almeida S., Gao F.-B. C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat. Neurosci. 2019;22:851&#x2013;862. doi: 10.1038/s41593-019-0397-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0397-0</ArticleId><ArticleId IdType="pmc">PMC6800116</ArticleId><ArticleId IdType="pubmed">31086314</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Donnelly C.J., Haeusler A.R., Grima J.C., Machamer J.B., Steinwald P., Daley E.L., Miller S.J., Cunningham K.M., Vidensky S., et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525:56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Bogaert E., Michiels E., Gijselinck I., Sieben A., Jovi&#x10d;i&#x107; A., De Baets G., Scheveneels W., Steyaert J., Cuijt I., et al. Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Sci. Rep. 2016;6:20877. doi: 10.1038/srep20877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20877</ArticleId><ArticleId IdType="pmc">PMC4751451</ArticleId><ArticleId IdType="pubmed">26869068</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosravi B., Hartmann H., May S., M&#xf6;hl C., Ederle H., Michaelsen M., Schludi M.H., Dormann D., Edbauer D. Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS/FTLD. Hum. Mol. Genet. 2017;26:790&#x2013;800. doi: 10.1093/hmg/ddw432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw432</ArticleId><ArticleId IdType="pmc">PMC5409121</ArticleId><ArticleId IdType="pubmed">28040728</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q., Zhou J.-W. Neuroinflammation in the central nervous system: Symphony of glial cells. Glia. 2019;67:1017&#x2013;1035. doi: 10.1002/glia.23571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23571</ArticleId><ArticleId IdType="pubmed">30548343</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M., Fatemi A. Pathologic role of glial nitric oxide in adult and pediatric neuroinflammatory diseases. Neurosci. Biobehav. Rev. 2014;45:168&#x2013;182. doi: 10.1016/j.neubiorev.2014.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2014.06.002</ArticleId><ArticleId IdType="pubmed">24933692</ArticleId></ArticleIdList></Reference><Reference><Citation>Block M.L., Zecca L., Hong J.-S. Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007;8:57&#x2013;69. doi: 10.1038/nrn2038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2038</ArticleId><ArticleId IdType="pubmed">17180163</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., Mehler M.F., Conway S.J., Ng L.G., Stanley E.R., et al. Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages. Science. 2010;330:841&#x2013;845. doi: 10.1126/science.1194637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1194637</ArticleId><ArticleId IdType="pmc">PMC3719181</ArticleId><ArticleId IdType="pubmed">20966214</ArticleId></ArticleIdList></Reference><Reference><Citation>Aarum J., Sandberg K., Haeberlein S.L.B., Persson M.A. Migration and differentiation of neural precursor cells can be directed by microglia. Proc. Natl. Acad. Sci. USA. 2003;100:15983&#x2013;15988. doi: 10.1073/pnas.2237050100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2237050100</ArticleId><ArticleId IdType="pmc">PMC307679</ArticleId><ArticleId IdType="pubmed">14668448</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettenmann H., Hanisch U.-K., Noda M., Verkhratsky A. Physiology of Microglia. Physiol. Rev. 2011;91:461&#x2013;553. doi: 10.1152/physrev.00011.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00011.2010</ArticleId><ArticleId IdType="pubmed">21527731</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S.C., Taylor D.L., Pocock J.M. Microglia release activators of neuronal proliferation mediated by activation of mitogen-activated protein kinase, phosphatidylinositol-3-kinase/Akt and delta-Notch signalling cascades. J. Neurochem. 2004;90:89&#x2013;101. doi: 10.1111/j.1471-4159.2004.02461.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02461.x</ArticleId><ArticleId IdType="pubmed">15198670</ArticleId></ArticleIdList></Reference><Reference><Citation>Simard M., Nedergaard M. The neurobiology of glia in the context of water and ion homeostasis. Neuroscience. 2004;129:877&#x2013;896. doi: 10.1016/j.neuroscience.2004.09.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2004.09.053</ArticleId><ArticleId IdType="pubmed">15561405</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Li J., Zheng J., Qin S. Reactive Astrocytes in Neurodegenerative Diseases. Aging Dis. 2019;10:664&#x2013;675. doi: 10.14336/AD.2018.0720.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2018.0720</ArticleId><ArticleId IdType="pmc">PMC6538217</ArticleId><ArticleId IdType="pubmed">31165009</ArticleId></ArticleIdList></Reference><Reference><Citation>Kacerovsky J.B., Murai K.K. Stargazing: Monitoring subcellular dynamics of brain astrocytes. Neuroscience. 2016;323:84&#x2013;95. doi: 10.1016/j.neuroscience.2015.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.07.007</ArticleId><ArticleId IdType="pubmed">26162237</ArticleId></ArticleIdList></Reference><Reference><Citation>Volterra A., Meldolesi J. Astrocytes, from brain glue to communication elements: The revolution continues. Nat. Rev. Neurosci. 2005;6:626&#x2013;640. doi: 10.1038/nrn1722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1722</ArticleId><ArticleId IdType="pubmed">16025096</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Barres B.A. Reactive Astrocytes: Production, Function, and Therapeutic Potential. Immunity. 2017;46:957&#x2013;967. doi: 10.1016/j.immuni.2017.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.06.006</ArticleId><ArticleId IdType="pubmed">28636962</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamanian J.L., Xu L., Foo L.C., Nouri N., Zhou L., Giffard R.G., Barres B.A. Genomic Analysis of Reactive Astrogliosis. J. Neurosci. 2012;32:6391&#x2013;6410. doi: 10.1523/JNEUROSCI.6221-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.6221-11.2012</ArticleId><ArticleId IdType="pmc">PMC3480225</ArticleId><ArticleId IdType="pubmed">22553043</ArticleId></ArticleIdList></Reference><Reference><Citation>Lall D., Baloh R.H. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia. J. Clin. Investig. 2017;127:3250&#x2013;3258. doi: 10.1172/JCI90607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI90607</ArticleId><ArticleId IdType="pmc">PMC5669558</ArticleId><ArticleId IdType="pubmed">28737506</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Q., Yang M., Liang C., Ma L., Zhang W., Jiang Z., Luo J., Lee J.-K., Liang C., Chen J.-F. C9orf72 and smcr8 mutant mice reveal MTORC1 activation due to impaired lysosomal degradation and exocytosis. Autophagy. 2020;16:1635&#x2013;1650. doi: 10.1080/15548627.2019.1703353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1703353</ArticleId><ArticleId IdType="pubmed">31847700</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho W.Y., Navakkode S., Liu F., Soong T.W., Ling S.-C. Deregulated expression of a longevity gene, Klotho, in the C9orf72 deletion mice with impaired synaptic plasticity and adult hippocampal neurogenesis. Acta Neuropathol. Commun. 2020;8:155. doi: 10.1186/s40478-020-01030-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01030-4</ArticleId><ArticleId IdType="pmc">PMC7473815</ArticleId><ArticleId IdType="pubmed">32887666</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Belzil V.V., Batra R., Ross C.A., Gendron T.F., Pregent L.J., Murray M.E., Overstreet K.K., Piazza-Johnston A.E., Desaro P., et al. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat. Neurosci. 2015;18:1175&#x2013;1182. doi: 10.1038/nn.4065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4065</ArticleId><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Umoh M.E., Dammer E.B., Dai J., Duong D.M., Lah J.J., Levey A.I., Gearing M., Glass J.D., Seyfried N.T. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain. EMBO Mol. Med. 2018;10:48&#x2013;62. doi: 10.15252/emmm.201708202.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201708202</ArticleId><ArticleId IdType="pmc">PMC5760858</ArticleId><ArticleId IdType="pubmed">29191947</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckl P., Weydt P., Steinacker P., Anderl-Straub S., Nordin F., Volk A.E., Diehl-Schmid J., Andersen P.M., Kornhuber J., Danek A., et al. Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase. J. Neurol. Neurosurg. Psychiatry. 2019;90:4&#x2013;10. doi: 10.1136/jnnp-2018-318868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318868</ArticleId><ArticleId IdType="pubmed">30224549</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Pattamatta A., Zu T., Reid T., Bardhi O., Borchelt D.R., Yachnis A.T., Ranum L.P.W. C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD. Neuron. 2016;90:521&#x2013;534. doi: 10.1016/j.neuron.2016.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Cistaro A., Pagani M., Montuschi A., Calvo A., Moglia C., Canosa A., Restagno G., Brunetti M., Traynor B.J., Nobili F., et al. The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. Eur. J. Nucl. Med. Mol. Imaging. 2014;41:844&#x2013;852. doi: 10.1007/s00259-013-2667-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-013-2667-5</ArticleId><ArticleId IdType="pubmed">24445987</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Toledo J.B., Van Deerlin V.M., Elman L., McCluskey L., Lee V.M.-Y., Trojanowski J.Q. Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis. PLoS ONE. 2012;7:e39216. doi: 10.1371/journal.pone.0039216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039216</ArticleId><ArticleId IdType="pmc">PMC3375234</ArticleId><ArticleId IdType="pubmed">22720079</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardenas A.M., Sarlls J.E., Kwan J.Y., Bageac D., Gala Z.S., Danielian L.E., Ray-Chaudhury A., Wang H.-W., Miller K.L., Foxley S., et al. Pathology of callosal damage in ALS: An ex-vivo, 7 T diffusion tensor MRI study. NeuroImage Clin. 2017;15:200&#x2013;208. doi: 10.1016/j.nicl.2017.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.04.024</ArticleId><ArticleId IdType="pmc">PMC5429246</ArticleId><ArticleId IdType="pubmed">28529876</ArticleId></ArticleIdList></Reference><Reference><Citation>Heller C., Foiani M.S., Moore K.M., Convery R.S., Bocchetta M., Neason M., Cash D.M., Thomas D.L., Greaves C.V., Woollacott I.O.C., et al. Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry. 2020;91:263&#x2013;270. doi: 10.1136/jnnp-2019-321954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-321954</ArticleId><ArticleId IdType="pubmed">31937580</ArticleId></ArticleIdList></Reference><Reference><Citation>Chistiakov D.A., Killingsworth M.C., Myasoedova V.A., Orekhov A.N., Bobryshev Y.V. CD68/macrosialin: Not just a histochemical marker. Lab. Investig. 2017;97:4&#x2013;13. doi: 10.1038/labinvest.2016.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2016.116</ArticleId><ArticleId IdType="pubmed">27869795</ArticleId></ArticleIdList></Reference><Reference><Citation>Zotova E., Bharambe V., Cheaveau M., Morgan W., Holmes C., Harris S., Neal J.W., Love S., Nicoll J.A.R., Boche D. Inflammatory components in human Alzheimer&#x2019;s disease and after active amyloid-&#x3b2;42 immunization. Brain. 2013;136:2677&#x2013;2696. doi: 10.1093/brain/awt210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt210</ArticleId><ArticleId IdType="pubmed">23943781</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker D.G., Lue L.-F. Immune phenotypes of microglia in human neurodegenerative disease: Challenges to detecting microglial polarization in human brains. Alzheimer&#x2019;s Res. Ther. 2015;7:56. doi: 10.1186/s13195-015-0139-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-015-0139-9</ArticleId><ArticleId IdType="pmc">PMC4543480</ArticleId><ArticleId IdType="pubmed">26286145</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez F.O., Helming L., Milde R., Varin A., Melgert B.N., Draijer C., Thomas B., Fabbri M., Crawshaw A., Ho L.P., et al. Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: Similarities and differences. Blood. 2013;121:e57&#x2013;e69. doi: 10.1182/blood-2012-06-436212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2012-06-436212</ArticleId><ArticleId IdType="pubmed">23293084</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito D., Imai Y., Ohsawa K., Nakajima K., Fukuuchi Y., Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Mol. Brain Res. 1998;57:1&#x2013;9. doi: 10.1016/S0169-328X(98)00040-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-328X(98)00040-0</ArticleId><ArticleId IdType="pubmed">9630473</ArticleId></ArticleIdList></Reference><Reference><Citation>Ising C., Venegas C., Zhang S., Scheiblich H., Schmidt S.V., Vieira-Saecker A., Schwartz S., Albasset S., McManus R.M., Tejera D., et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575:669&#x2013;673. doi: 10.1038/s41586-019-1769-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1769-z</ArticleId><ArticleId IdType="pmc">PMC7324015</ArticleId><ArticleId IdType="pubmed">31748742</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominy S.S., Lynch C., Ermini F., Benedyk M., Marczyk A., Konradi A., Nguyen M., Haditsch U., Raha D., Griffin C., et al. Porphyromonas gingivalis in Alzheimer&#x2019;s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci. Adv. 2019;5:eaau3333. doi: 10.1126/sciadv.aau3333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aau3333</ArticleId><ArticleId IdType="pmc">PMC6357742</ArticleId><ArticleId IdType="pubmed">30746447</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohsawa K., Imai Y., Sasaki Y., Kohsaka S. Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity. J. Neurochem. 2004;88:844&#x2013;856. doi: 10.1046/j.1471-4159.2003.02213.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.02213.x</ArticleId><ArticleId IdType="pubmed">14756805</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S., Lashley T., Norona F.E., Clayton E.L., Ridler C.E., Fratta P., Isaacs A.M. C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci. Acta Neuropathol. 2013;126:845&#x2013;857. doi: 10.1007/s00401-013-1200-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1200-z</ArticleId><ArticleId IdType="pmc">PMC3830745</ArticleId><ArticleId IdType="pubmed">24170096</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Finch N.A., Wang X., Gendron T.F., Bieniek K.F., Heckman M.G., Vasilevich A., Murray M.E., Rousseau L., Weesner R., et al. In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers. Acta Neuropathol. 2017;134:255&#x2013;269. doi: 10.1007/s00401-017-1725-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1725-7</ArticleId><ArticleId IdType="pmc">PMC5508036</ArticleId><ArticleId IdType="pubmed">28508101</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKenzie I.R., Arzberger T., Kremmer E., Troost D., Lorenzl S., Mori K., Weng S.-M., Haass C., Kretzschmar H.A., Edbauer D., et al. Dipeptide repeat protein pathology in C9ORF72 mutation cases: Clinico-pathological correlations. Acta Neuropathol. 2013;126:859&#x2013;879. doi: 10.1007/s00401-013-1181-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1181-y</ArticleId><ArticleId IdType="pubmed">24096617</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S., Stauffer J.E., Jiang J., Garcia S.D., Taylor A.E., Schulte D., Ohkubo T., Schloffman C.L., Maldonado M., Baughn M., et al. Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol. 2018;135:459&#x2013;474. doi: 10.1007/s00401-017-1793-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1793-8</ArticleId><ArticleId IdType="pmc">PMC5935138</ArticleId><ArticleId IdType="pubmed">29196813</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters O.M., Cabrera G.T., Tran H., Gendron T.F., McKeon J.E., Metterville J., Weiss A., Wightman N., Salameh J., Kim J., et al. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice. Neuron. 2015;88:902&#x2013;909. doi: 10.1016/j.neuron.2015.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.11.018</ArticleId><ArticleId IdType="pmc">PMC4828340</ArticleId><ArticleId IdType="pubmed">26637797</ArticleId></ArticleIdList></Reference><Reference><Citation>Westergard T., Jensen B.K., Wen X., Cai J., Kropf E., Iacovitti L., Pasinelli P., Trotti D. Cell-to-Cell Transmission of Dipeptide Repeat Proteins Linked to C9orf72-ALS/FTD. Cell Rep. 2016;17:645&#x2013;652. doi: 10.1016/j.celrep.2016.09.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.09.032</ArticleId><ArticleId IdType="pmc">PMC5078984</ArticleId><ArticleId IdType="pubmed">27732842</ArticleId></ArticleIdList></Reference><Reference><Citation>Michell-Robinson M.A., Touil H., Healy L.M., Owen D.R., Durafourt B.A., Bar-Or A., Antel J.P., Moore C.S. Roles of microglia in brain development, tissue maintenance and repair. Brain. 2015;138:1138&#x2013;1159. doi: 10.1093/brain/awv066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv066</ArticleId><ArticleId IdType="pmc">PMC5963417</ArticleId><ArticleId IdType="pubmed">25823474</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A., Nedergaard M. Physiology of Astroglia. Physiol. Rev. 2018;98:239&#x2013;389. doi: 10.1152/physrev.00042.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00042.2016</ArticleId><ArticleId IdType="pmc">PMC6050349</ArticleId><ArticleId IdType="pubmed">29351512</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray M.E., DeJesus-Hernandez M., Rutherford N.J., Baker M., Duara R., Graff-Radford N.R., Wszolek Z.K., Ferman T.J., Josephs K.A., Boylan K.B., et al. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathol. 2011;122:673&#x2013;690. doi: 10.1007/s00401-011-0907-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0907-y</ArticleId><ArticleId IdType="pmc">PMC3277860</ArticleId><ArticleId IdType="pubmed">22083254</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Arai K., Del Tredici K., Toledo J.B., Robinson J.L., Lee E.B., Kuwabara S., Shibuya K., Irwin D.J., Fang L., et al. TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol. 2014;128:423&#x2013;437. doi: 10.1007/s00401-014-1299-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1299-6</ArticleId><ArticleId IdType="pmc">PMC4384652</ArticleId><ArticleId IdType="pubmed">24916269</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatima M., Tan R., Halliday G.M., Kril J.J. Spread of pathology in amyotrophic lateral sclerosis: Assessment of phosphorylated TDP-43 along axonal pathways. Acta Neuropathol. Commun. 2015;3:47. doi: 10.1186/s40478-015-0226-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0226-y</ArticleId><ArticleId IdType="pmc">PMC4517552</ArticleId><ArticleId IdType="pubmed">26216351</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K., Ferraiuolo L., Miranda C.J., Likhite S., McElroy S., Renusch S., Ditsworth D., Lagier-Tourenne C., Smith R.A., Ravits J., et al. Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc. Natl. Acad. Sci. USA. 2014;111:829&#x2013;832. doi: 10.1073/pnas.1314085111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1314085111</ArticleId><ArticleId IdType="pmc">PMC3896192</ArticleId><ArticleId IdType="pubmed">24379375</ArticleId></ArticleIdList></Reference><Reference><Citation>Madill M., McDonagh K., Ma J., Vajda A., McLoughlin P., O&#x2019;Brien T., Hardiman O., Shen S. Amyotrophic lateral sclerosis patient iPSC-derived astrocytes impair autophagy via non-cell autonomous mechanisms. Mol. Brain. 2017;10:22. doi: 10.1186/s13041-017-0300-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0300-4</ArticleId><ArticleId IdType="pmc">PMC5470320</ArticleId><ArticleId IdType="pubmed">28610619</ArticleId></ArticleIdList></Reference><Reference><Citation>Varcianna A., Myszczynska M.A., Castelli L.M., O&#x2019;Neill B., Kim Y., Talbot J., Nyberg S., Nyamali I., Heath P.R., Stopford M.J., et al. Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS. EBioMedicine. 2019;40:626&#x2013;635. doi: 10.1016/j.ebiom.2018.11.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.11.067</ArticleId><ArticleId IdType="pmc">PMC6413467</ArticleId><ArticleId IdType="pubmed">30711519</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S.P., Hall B., Castelli L.M., Francis L., Woof R., Siskos A.P., Kouloura E., Gray E., Thompson A.G., Talbot K., et al. Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis. Brain. 2019;142:586&#x2013;605. doi: 10.1093/brain/awy353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy353</ArticleId><ArticleId IdType="pmc">PMC6391613</ArticleId><ArticleId IdType="pubmed">30698736</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S.P., Hall B., Woof R., Francis L., Gatto N., Shaw A.C., Myszczynska M., Hemingway J., Coldicott I., Willcock A., et al. C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis. Brain. 2019;142:3771&#x2013;3790. doi: 10.1093/brain/awz302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz302</ArticleId><ArticleId IdType="pmc">PMC6906594</ArticleId><ArticleId IdType="pubmed">31647549</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto E., Colombrita C., Gumina V., Borghi M.O., Dusi S., Doretti A., Fagiolari G., Invernizzi F., Moggio M., Tiranti V., et al. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathol. Commun. 2016;4:47. doi: 10.1186/s40478-016-0316-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0316-5</ArticleId><ArticleId IdType="pmc">PMC4858818</ArticleId><ArticleId IdType="pubmed">27151080</ArticleId></ArticleIdList></Reference><Reference><Citation>Fomin V., Richard P., Hoque M., Li C., Gu Z., Fissore-O&#x2019;Leary M., Tian B., Prives C., Manley J.L. The C9ORF72 Gene, Implicated in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia, Encodes a Protein That Functions in Control of Endothelin and Glutamate Signaling. Mol. Cell. Biol. 2018;38:e00155-18. doi: 10.1128/MCB.00155-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00155-18</ArticleId><ArticleId IdType="pmc">PMC6206455</ArticleId><ArticleId IdType="pubmed">30150298</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Antoni S., Ranno E., Spatuzza M., Cavallaro S., Catania M.V. Endothelin-1 Induces Degeneration of Cultured Motor Neurons through a Mechanism Mediated by Nitric Oxide and PI3K/Akt Pathway. Neurotox. Res. 2017;32:58&#x2013;70. doi: 10.1007/s12640-017-9711-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-017-9711-3</ArticleId><ArticleId IdType="pubmed">28285347</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostalski H., Leskel&#xe4; S., Huber N., Katisko K., Cajanus A., Solje E., Marttinen M., Natunen T., Remes A.M., Hiltunen M., et al. Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS. Front. Neurosci. 2019;13:486. doi: 10.3389/fnins.2019.00486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00486</ArticleId><ArticleId IdType="pmc">PMC6529740</ArticleId><ArticleId IdType="pubmed">31156371</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddique N., Siddique T. Amyotrophic Lateral Sclerosis Overview. In: Adam M.P., Ardinger H.H., Pagon R.A., Wallace S.E., Bean L.J.H., Stephens K., Amemiya A., editors. GeneReviews&#xae;. University of Washington; Seattle, WA, USA: 1993.</Citation></Reference><Reference><Citation>Goutman S.A., Chen K.S., Paez-Colasante X., Feldman E.L. Emerging understanding of the genotype&#x2013;phenotype relationship in amyotrophic lateral sclerosis. Handb. Clin.Neurol. 2018;148:603&#x2013;623. doi: 10.1016/b978-0-444-64076-5.00039-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/b978-0-444-64076-5.00039-9</ArticleId><ArticleId IdType="pubmed">29478603</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron T.F., Van Blitterswijk M., Bieniek K.F., Daughrity L.M., Jiang J., Rush B.K., Pedraza O., Lucas J.A., Murray M.E., Desaro P., et al. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers. Acta Neuropathol. 2015;130:559&#x2013;573. doi: 10.1007/s00401-015-1474-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1474-4</ArticleId><ArticleId IdType="pmc">PMC4575385</ArticleId><ArticleId IdType="pubmed">26350237</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi M.H., May S., Gr&#xe4;sser F.A., Rentzsch K., Kremmer E., K&#xfc;pper C., Klopstock T., German Consortium for Frontotemporal Lobar Degeneration. Bavarian Brain Banking Alliance. Arzberger T., et al. Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing. Acta Neuropathol. 2015;130:537&#x2013;555. doi: 10.1007/s00401-015-1450-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1450-z</ArticleId><ArticleId IdType="pmc">PMC4575390</ArticleId><ArticleId IdType="pubmed">26085200</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron T.F., Chew J., Stankowski J.N., Hayes L.R., Zhang Y.-J., Prudencio M., Carlomagno Y., Daughrity L.M., Jansen-West K., Perkerson E.A., et al. Poly(GP) proteins are a useful pharmacodynamic marker forC9ORF72-associated amyotrophic lateral sclerosis. Sci. Transl. Med. 2017;9:eaai7866. doi: 10.1126/scitranslmed.aai7866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aai7866</ArticleId><ArticleId IdType="pmc">PMC5576451</ArticleId><ArticleId IdType="pubmed">28356511</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardani R., Mancinelli E., Giagnacovo M., Sansone V., Meola G. Ribonuclear inclusions as biomarker of myotonic dystrophy type 2, even in improperly frozen or defrozen skeletal muscle biopsies. Eur. J. Histochem. 2009;53:107&#x2013;111. doi: 10.4081/ejh.2009.e13.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/ejh.2009.e13</ArticleId><ArticleId IdType="pubmed">19683984</ArticleId></ArticleIdList></Reference><Reference><Citation>Ransohoff R.M. How neuroinflammation contributes to neurodegeneration. Science. 2016;353:777&#x2013;783. doi: 10.1126/science.aag2590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aag2590</ArticleId><ArticleId IdType="pubmed">27540165</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins M.A., An J., Hood B.L., Conrads T.P., Bowser R.P. Label-Free LC&#x2013;MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis. J. Proteome Res. 2015;14:4486&#x2013;4501. doi: 10.1021/acs.jproteome.5b00804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.5b00804</ArticleId><ArticleId IdType="pmc">PMC5592736</ArticleId><ArticleId IdType="pubmed">26401960</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Liu X.-H., Wu J.-J., Ren H.-M., Wang J., Ding Z.-T., Jiang Y.-P. Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis. Exp. Ther. Med. 2016;11:2095&#x2013;2106. doi: 10.3892/etm.2016.3210.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2016.3210</ArticleId><ArticleId IdType="pmc">PMC4887813</ArticleId><ArticleId IdType="pubmed">27284291</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Chen Y., Wei Q.-Q., Ou R., Cao B., Zhao B., Shang H. Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis. BMC Neurol. 2016;16:173. doi: 10.1186/s12883-016-0689-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-016-0689-x</ArticleId><ArticleId IdType="pmc">PMC5024522</ArticleId><ArticleId IdType="pubmed">27634542</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau C., Gosset P., Brunaud-Danel V., Lassalle P., Degonne B., Dest&#xe9;e A., Defebvre L., Devos D. CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients. Amyotroph. Lateral Scler. 2009;10:175&#x2013;181. doi: 10.1080/17482960802651725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802651725</ArticleId><ArticleId IdType="pubmed">19177252</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu L.T., Bowser R.P. Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis. Neurotherapeutics. 2017;14:119&#x2013;134. doi: 10.1007/s13311-016-0503-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-016-0503-x</ArticleId><ArticleId IdType="pmc">PMC5233638</ArticleId><ArticleId IdType="pubmed">27933485</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail A., Cooper-Knock J., Highley J.R., Milano A., Kirby J., Goodall E., Lowe J., Scott I., Constantinescu C.S., Walters S.J., et al. Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72. J. Neurol. Neurosurg. Psychiatry. 2013;84:79&#x2013;87. doi: 10.1136/jnnp-2012-303326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-303326</ArticleId><ArticleId IdType="pubmed">23085936</ArticleId></ArticleIdList></Reference><Reference><Citation>Katisko K., Solje E., Korhonen P., J&#xe4;&#xe4;skel&#xe4;inen O., Loppi S., Hartikainen P., Koivisto A.M., Kontkanen A., Korhonen V.E., Helisalmi S., et al. Peripheral inflammatory markers and clinical correlations in patients with frontotemporal lobar degeneration with and without the C9orf72 repeat expansion. J. Neurol. 2020;267:76&#x2013;86. doi: 10.1007/s00415-019-09552-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09552-1</ArticleId><ArticleId IdType="pmc">PMC6954907</ArticleId><ArticleId IdType="pubmed">31559531</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett S.A., Tanaz R., Cobos S.N., Torrente M.P. Epigenetics in amyotrophic lateral sclerosis: A role for histone post-translational modifications in neurodegenerative disease. Transl. Res. 2019;204:19&#x2013;30. doi: 10.1016/j.trsl.2018.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2018.10.002</ArticleId><ArticleId IdType="pmc">PMC6331271</ArticleId><ArticleId IdType="pubmed">30391475</ArticleId></ArticleIdList></Reference><Reference><Citation>Benigni M., Ricci C., Jones A.R., Giannini F., Al-Chalabi A., Battistini S. Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients. NeuroMolecular Med. 2016;18:551&#x2013;560. doi: 10.1007/s12017-016-8396-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-016-8396-8</ArticleId><ArticleId IdType="pubmed">27119371</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B., Annunziata A., Fiorentino G., Borra M., Biffali E., Coppola C., Cotrufo R., Brettschneider J., Giordana M.L., Dalmay T., et al. miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients. Neurogenetics. 2014;15:243&#x2013;253. doi: 10.1007/s10048-014-0420-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-014-0420-2</ArticleId><ArticleId IdType="pubmed">25130371</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi I., Hama Y., Matsushima M., Hirotani M., Kano T., Hohzen H., Yabe I., Utsumi J., Sasaki H. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis. Mol. Brain. 2015;8:67. doi: 10.1186/s13041-015-0161-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0161-7</ArticleId><ArticleId IdType="pmc">PMC4619470</ArticleId><ArticleId IdType="pubmed">26497046</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., M&#xfc;ller K., Ludolph A., Weishaupt J. Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2013;1:42. doi: 10.1186/2051-5960-1-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-1-42</ArticleId><ArticleId IdType="pmc">PMC3893596</ArticleId><ArticleId IdType="pubmed">24252274</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams A.H., Valdez G., Moresi V., Qi X., McAnally J., Elliott J.L., Bassel-Duby R., Sanes J.R., Olson E.N. MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in Mice. Science. 2009;326:1549&#x2013;1554. doi: 10.1126/science.1181046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowser R., Turner M.R., Shefner J.M. Biomarkers in amyotrophic lateral sclerosis: Opportunities and limitations. Nat. Rev. Neurol. 2011;7:631&#x2013;638. doi: 10.1038/nrneurol.2011.151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.151</ArticleId><ArticleId IdType="pubmed">21989244</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez E.F., Sattler R. Biomarker development for C9orf72 repeat expansion in ALS. Brain Res. 2015;1607:26&#x2013;35. doi: 10.1016/j.brainres.2014.09.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.09.041</ArticleId><ArticleId IdType="pubmed">25261695</ArticleId></ArticleIdList></Reference><Reference><Citation>De Godoy Rousseff Prado L., Bicalho I.C.S., Magalh&#xe3;es D., Caramelli P., Teixeira A.L., De Souza L.C. C9ORF72 and the FTD-ALS spectrum: A systematic review of neuroimaging studies. Dement. Neuropsychol. 2015;9:413&#x2013;421. doi: 10.1590/1980-57642015DN94000413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1980-57642015DN94000413</ArticleId><ArticleId IdType="pmc">PMC5619324</ArticleId><ArticleId IdType="pubmed">29213991</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeve B.F., Boylan K.B., Graff-Radford N.R., DeJesus-Hernandez M., Knopman D.S., Pedraza O., Vemuri P., Jones D., Lowe V., Murray M.E., et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain. 2012;135:765&#x2013;783. doi: 10.1093/brain/aws004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws004</ArticleId><ArticleId IdType="pmc">PMC3286335</ArticleId><ArticleId IdType="pubmed">22366793</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney C.J., Beck J., Rohrer J.D., Lashley T., Mok K., Shakespeare T., Yeatman T., Warrington E.K., Schott J.M., Fox N.C., et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: Clinical, neuroanatomical and neuropathological features. Brain. 2012;135:736&#x2013;750. doi: 10.1093/brain/awr361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr361</ArticleId><ArticleId IdType="pmc">PMC3286330</ArticleId><ArticleId IdType="pubmed">22366791</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Bokde A.L., Byrne S., Elamin M., McLaughlin R.L., Kenna K., Fagan A.J., Pender N., Bradley D.G., Hardiman O. Multiparametric MRI study of ALS stratified for the C9orf72 genotype. Neurology. 2013;81:361&#x2013;369. doi: 10.1212/WNL.0b013e31829c5eee.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31829c5eee</ArticleId><ArticleId IdType="pmc">PMC3772833</ArticleId><ArticleId IdType="pubmed">23771489</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew S., Atassi N. Positron Emission Tomography Molecular Imaging Biomarkers for Amyotrophic Lateral Sclerosis. Front. Neurol. 2019;10:135. doi: 10.3389/fneur.2019.00135.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00135</ArticleId><ArticleId IdType="pmc">PMC6405430</ArticleId><ArticleId IdType="pubmed">30881332</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xfc;rcher N.R., Loggia M.L., Lawson R., Chonde D.B., Izquierdo-Garcia D., Yasek J.E., Akeju O., Catana C., Rosen B.R., Cudkowicz M.E., et al. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [11C]-PBR28. NeuroImage Clin. 2015;7:409&#x2013;414. doi: 10.1016/j.nicl.2015.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2015.01.009</ArticleId><ArticleId IdType="pmc">PMC4310932</ArticleId><ArticleId IdType="pubmed">25685708</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshikho M.J., Z&#xfc;rcher N.R., Loggia M., Cernasov P., Reynolds B., Pijanowski O., Chonde D.B., Izquierdo-Garcia D., Mainero C., Catana C., et al. Integrated magnetic resonance imaging and [11C]-PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosis. Ann. Neurol. 2018;83:1186&#x2013;1197. doi: 10.1002/ana.25251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25251</ArticleId><ArticleId IdType="pmc">PMC6105567</ArticleId><ArticleId IdType="pubmed">29740862</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshikho M.J., Z&#xfc;rcher N.R., Loggia M.L., Cernasov P., Chonde D.B., Izquierdo-Garcia D., Yasek J.E., Akeju O., Catana C., Rosen B.R., et al. Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis. Neurology. 2016;87:2554&#x2013;2561. doi: 10.1212/WNL.0000000000003427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003427</ArticleId><ArticleId IdType="pmc">PMC5207001</ArticleId><ArticleId IdType="pubmed">27837005</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolgin E. The brain&#x2019;s traffic problems. Science. 2019;363:221&#x2013;223. doi: 10.1126/science.363.6424.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.363.6424.221</ArticleId><ArticleId IdType="pubmed">30655425</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>